AKR1B10 抗体

Berard, Coombs, Severini: "Quantification of the host response proteome after herpes simplex virus type 1 infection." in: Journal of proteome research, Vol. 14, Issue 5, pp. 2121-42, (2015) (PubMed).

Matkowskyj, Bai, Liao, Zhang, Li, Rao, Omary, Yang: "Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions." in: Human pathology, Vol. 45, Issue 4, pp. 834-43, (2014) (PubMed).

Jin, Yu, Dong, Zhou, Gu, Yu, Yu, Lu, Xian, Liu, Cong, Wu: "SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma." in: Journal of hepatology, Vol. 59, Issue 3, pp. 510-7, (2013) (PubMed).

Chung, Matkowskyj, Li, Bai, Zhang, Tsao, Liao, Yang: "Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 25, Issue 5, pp. 758-66, (2012) (PubMed).

Moriguchi, Zhang, Mihara, Sato: "A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals." in: Scientific reports, Vol. 2, pp. 280, (2012) (PubMed).

Nelson, Pillay, Henderson, Presneau, Tirabosco, Halai, Berisha, Flicek, Stemple, Stern, Wardle, Flanagan: "An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma." in: The Journal of pathology, Vol. 228, Issue 3, pp. 274-85, (2012) (PubMed).

Ebert, Kisiela, Wsól, Maser: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).

Schmitz, Sotiropoulos, Baba, Schmid, Müller, Paul, Auer, Gamerith, Loeffler-Ragg: "AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 31, Issue 6, pp. 810-6, (2011) (PubMed).

Díez-Dacal, Gayarre, Gharbi, Timms, Coderch, Gago, Pérez-Sala: "Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity." in: Cancer research, Vol. 71, Issue 12, pp. 4161-71, (2011) (PubMed).

Bains, Grigliatti, Reid, Riggs: "Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin." in: The Journal of pharmacology and experimental therapeutics, Vol. 335, Issue 3, pp. 533-45, (2010) (PubMed).